Compound ID	CDAMM02551
Common name	Cadambine
IUPAC name	methyl 17-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-18,23-dioxa-3,13-diazahexacyclo[13.7.1.01,13.02,10.04,9.016,21]tricosa-2(10),4,6,8,19-pentaene-20-carboxylate
Molecular formula	C₂₇H₃₂N₂O₁₀

Experimental data

Retention time	4.36
Adduct	[M+H]+
Actual mz	545.215
Theoretical mz	545.213
Error	3.35
Ionizaton mode	Positive
Instrument type	LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score	7.5023

Identifiers and class information

Inchi key	OVRROYYXOBYCSR-CZAVMTDFNA-N
Smiles	O=C(OC)C1=COC(OC2OC(CO)C(O)C(O)C2O)C3C4OC5(C=6NC=7C=CC=CC7C6CCN5C4)CC13
Superclass	Organoheterocyclic compounds
Class	Indoles and derivatives

Plant source

Convolvulus prostratus Forssk.

External sources

HMDB ID
KNApSAcK ID	C00025157
FooDB ID
DrugBank ID
ChEBI ID
Pubchem Compound ID	398038
PlantCyc ID
UNPD ID	UNPD107464
Coconut ID	CNP0232893
LipidMAPS ID
NANPDB ID

Pharmacokinetic properties

Number of descriptor values(#stars)	0
Number of non-conjugated amine groups (#amine)	1
Number of amidine and guanidine groups (#amidine)	0
Number of carboxylic acid groups (#acid)	0
Number of non-conjugated amide groups (#amide)	0
Number of rotatable bonds (#rotor)	8
Number of reactive functional groups (#rtvFG)	3
Predicted central nervous system activity (CNS)	-2
Molecular weight (mol_MW)	544.557
Computed dipole moment(dipole)	4.689
Total solvent accessible surface area (SASA)	782.708
Hydrophobic component of SASA (FOSA)	367.185
Hydrophilic component of SASA (FISA)	205.95
Pie component of the SASA (PISA)	209.573
Weakly polar component of the SASA (WPSA)	0
Total solvent accesible volume (volume)	1493.81
Number of hydrogen bond donors (donorHB)	5
Number of hydrogen bond acceptors (accptHB)	15.65
Free energy of solvation of dipole (dip^2/V)	0.0147212
Index of cohesive interaction in solids (ACxDN^.5/SA)	0.0447094
Globularity descriptor (glob)	0.807414
Predicted polarizability in cubic angstroms (QPpolrz)	50.493
Predicted hexadecane/gas partition coefficient (QPlogPC16)	16.145
Predicted octanol/gas partition coefficient (QPlogPoct)	33.018
Predicted water/gas partition coefficient (QPlogPw)	25.403
Predicted octanol/water partition coefficient (QPlogPo/w)	0.196
Predicted aqueous solubility (QPlogS)	-2.794
Conformation-independent predicted aqueous solubility (CIQPlogS)	-3.708
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)	-6.374
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)	27.528
Predicted brain/blood partition coefficient (QPlogBB)	-1.626
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)	11.267
Predicted skin permeability, log Kp (QPlogKp)	-5.871
PM3 calculated ionization potential (IP(ev))	8.221
PM3 calculated electron affinity (EA(eV))	0.21
Number of likely metabolic reactions (#metab)	7
Prediction of binding to human serum albumin (QPlogKhsa)	-0.556
Predicted qualitative human oral absorption (HumanOralAbsorption)	2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)	27.945
Solvent-accessible surface area of fluorine atoms (SAFluorine)	0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)	0
Van der Waals surface area (PSA)	165.84
Number of nitrogen and oxygen atoms (#NandO)	12
Number of violations of Lipinski’s rule of five (RuleOfFive)	2
Number of violations of Jorgensen’s rule of three (RuleOfThree)	1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID	Gene name	Target name	TTD_ID	Prediction source
P11387	TOP1	DNA topoisomerase I	T09826	SEA
P15692	VEGFA	Vascular endothelial growth factor A	T20761	SEA
P05230	FGF1	Acidic fibroblast growth factor	T18639	SEA
P09038	FGF2	Basic fibroblast growth factor	T31621	SEA
P60568	IL2	Interleukin-2	T61698	SEA
P17931	LGALS3	Galectin-3	T72038	SEA
P20916	MAG	Myelin-associated glycoprotein (by homology)	T95286	SEA

Target associated diseases

TTD_ID	Disease_ID	Disease name	ICD_11	Uniprot ID	Gene names
T09826	DI0046	Bacterial infection	[ICD-11: 1A00-1C4Z]	P11387	TOP1
T09826	DI0095	Colorectal cancer	[ICD-11: 2B91]	P11387	TOP1
T09826	DI0238	Lung cancer	[ICD-11: 2C25]	P11387	TOP1
T09826	DI0321	Ovarian cancer	[ICD-11: 2C73]	P11387	TOP1
T09826	DI0391	Solid tumour/cancer	[ICD-11: 2A00-2F9Z]	P11387	TOP1
T20761	DI0095	Colorectal cancer	[ICD-11: 2B91]	P15692	VEGFA
T20761	DI0365	Retinopathy	[ICD-11: 9B71]	P15692	VEGFA
T20761	DI0430	Vascular system developmental anomaly	[ICD-11: LA90]	P15692	VEGFA
T18639	DI0081	Chronic arterial occlusive disease	[ICD-11: BD4Z]	P05230	FGF1
T18639	DI0102	Coronary atherosclerosis	[ICD-11: BA52]	P05230	FGF1
T31621	DI0005	Acne vulgaris	[ICD-11: ED80]	P09038	FGF2
T61698	DI0275	Multiple sclerosis	[ICD-11: 8A40]	P60568	IL2
T61698	DI0361	Renal cell carcinoma	[ICD-11: 2C90]	P60568	IL2
T72038	DI0190	Hypertension	[ICD-11: BA00-BA04]	P17931	LGALS3
T72038	DI0199	Idiopathic interstitial pneumonitis	[ICD-11: CB03]	P17931	LGALS3
T72038	DI0252	Melanoma	[ICD-11: 2C30]	P17931	LGALS3
T72038	DI0302	Non-alcoholic fatty liver disease	[ICD-11: DB92]	P17931	LGALS3
T72038	DI0351	Psoriasis	[ICD-11: EA90]	P17931	LGALS3
T95286	DI0219	Ischaemic/haemorrhagic stroke	[ICD-11: 8B20]	P20916	MAG